PTNS, an electrical impulse treatment for overactive bladder, eased bladder and sexual issues for female RRMS patients in a ...

6, 2023 — Multiple sclerosis patients whose blood tests reveal elevated NfL, a biomarker of nerve damage, could see worsening disability one to two years later, according to a new ...

significantly reduced the blood levels of neurofilament light chain (NfL), a biomarker of nerve cell damage that typically is elevated in people with multiple sclerosis (MS). That’s according to ...

The Epstein–Barr virus (EBV), a member of the herpesvirus family, is best known for causing infectious mononucleosis, or ...

Multiple sclerosis (MS ... Internuclear ophthalmoplegia is common in MS and results from damage to interneurons travelling from the cranial nerve (CN) VI nucleus in the pons to the contralateral ...

A groundbreaking new treatment for multiple sclerosis is set to begin clinical trials in Greece by mid-2024, offering hope to ...

A recent study from Harvard University has provided strong evidence that infection with the Epstein-Barr virus (EBV), a type ...

A pioneering clinical trial in Cambridge is bringing renewed hope to those living with multiple sclerosis (MS), a condition where the immune system mistakenly attacks the protective covering of ...

Researchers at the University of Basel have uncovered that a drug for multiple sclerosis could also help sharpen working memory ... Fampridine targets specific ion channels in nerve cells that ...

Limiting the review to the period 1991–6, to exclude the “learning period” (the first 50 cases) and patients with less than 1 year follow up, surgical findings and results were critically analysed in ...

Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows ... Fampridine acts on specific ion channels in nerve cells that, according to the researchers ...